InsidersTradesSigma
삼성바이오로직스 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 삼성바이오로직스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 삼성바이오로직스 has published 2 public disclosures. Market capitalisation: €60,363.4bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 컨두잇. The full history is accessible without an account.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성바이오로직스 Strong Buy (bullish), based on 23 analysts. Average price target: ₩2,096,122.
Fundamental score
Ranked 8,075 of 26,270 companies
61.1
score / 100
Value38
Quality84
FCF yld1.2%
Earn yld2.7%
EV/EBITDA24.0x
ROE18%
Gross mgn55%
Net mgn39%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 March 2026